alegtuzumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for alegtuzumab, covering 2018-06-06 to 2018-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation [Phase 4]